Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1827462 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL1985823 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL2175496 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL2176899 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL2177991 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL2174526 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL132521 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL2173439 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL536857 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 | |
| SCHEMBL443449 | 1.00 | LMNA (0.43) | LMNAKDM4CTRPV1KDM4APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1766 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12285508-B2 | Hair treatment formulations and uses thereof | Chembeau LLC (US) | 2025-04-29 | — | — | US | claimed |
| US-12214065-B2 | Diester cosmetic formulations and uses thereof | Chembeau LLC (US) | 2025-02-04 | — | — | US | claimed |
| CN-118252761-A | Oral care compositions, their preparation and use | 苏州欧丽特生物医药有限公司 | 2024-06-28 | — | — | CN | claimed |
| EP-4375270-A1 | SUPRAMOLECULAR AMINO ACID OR SALT THEREOF, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Suzhou Oulit Biopharm Co., Ltd. (CN) | 2024-05-29 | — | — | EP | claimed |
| WO-2024078286-A1 | GEL COMPOSITION, AND PREPARATION AND USE THEREOF | 苏州欧丽特生物医药有限公司 | 2024-04-18 | — | — | WO | claimed |
| CN-117883307-A | Gel composition, preparation and application thereof | 苏州欧丽特生物医药有限公司 | 2024-04-16 | — | — | CN | claimed |
| EP-4321551-A1 | EXTENDED WORK TIME POLYASPARTIC FLOOR COATING FORMULATIONS | Covestro LLC (US) | 2024-02-14 | — | — | EP | claimed |
| CN-117479922-A | Thickening composition for thickening polar or nonpolar oils | 化工产品开发公司SEPPIC | 2024-01-30 | — | — | CN | claimed |
| WO-2023224846-A1 | EXTENDED WORK TIME POLYASPARTIC FLOOR COATING FORMULATIONS | COVESTRO LLC (US) | 2023-11-23 | — | — | WO | claimed |
| US-11801211-B2 | Hair treatment formulations and uses thereof | Chembeau LLC (US) | 2023-10-31 | — | — | US | claimed |
| US-4894224-A | COSMETICS, SKINS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1990-01-16 | — | — | US | claimed |
| US-4822601-A | MIXTURE OF SUCROSE FATTY ACID ESTER AND ACYL FATTY ACID LACTYLATE ESTER | R.I.T.A. CORPORATION (US) | 1989-04-18 | — | — | US | claimed |
| EP-0305493-A1 | COSMETIC BASE COMPOSITION WITH THERAPEUTIC PROPERTIES. | R I T A CORP (US) | 1989-03-08 | — | — | EP | claimed |
| WO-1988006880-A1 | COSMETIC BASE COMPOSITION WITH THERAPEUTIC PROPERTIES | R.I.T.A. CORPORATION (US) | 1988-09-22 | — | — | WO | claimed |
| US-4618436-A | BORATED OXAZOLINE ACID PHOSPHATE DERIVATIVES | MOBIL OIL CORPORATION (US) | 1986-10-21 | — | — | US | claimed |
| US-4591498-A | N-ACYL-N-METHYL-BETA-ALANINE OR ITS SALT; ETHYLENE OXIDE TYPE SURFACTANT | KAO CORPORATION (JP) | 1986-05-27 | — | — | US | claimed |
| US-4279888-A | SUGAR ALCOHOL FATTY ACID ESTER | LION CORPORATION (JP) | 1981-07-21 | — | — | US | claimed |
| US-4184978-A | Stable water in oil emulsion systems for cosmetic and pharmaceutical preparations | C. J. PATTERSON COMPANY (US) | 1980-01-22 | — | — | US | claimed |
| US-4141751-A | Process for preparing modified particulate and/or fibrous, crystalline and amorphous inorganic substances | MALVERN MINERALS COMPANY (US) | 1979-02-27 | — | — | US | claimed |
| US-4028378-A | Fatty and benzoic acid esters of ethoxylated hydantoins substituted or not in the 5-position | GLYCO CHEMICALS, INC. (US) | 1977-06-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11801211-B2 | Hair treatment formulations and uses thereof | FHIT, SUCLG1, TES | LMNA 839/4885KDM4C 1151/4885TRPV1 332/4885 |
| US-12214065-B2 | Diester cosmetic formulations and uses thereof | DAGLA, CYP19A1, CYP51A1 | LMNA 2313/4885KDM4C 3346/4885TRPV1 899/4885 |
| US-12285508-B2 | Hair treatment formulations and uses thereof | FHIT, SUCLG1, TES | LMNA 839/4885KDM4C 1151/4885TRPV1 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.